Is regorafenib a targeted drug or a chemotherapy drug?

Regorafenib (Regorafenib) is an oral multi-target inhibitor that is often classified as a targeted drug, especially in the treatment of malignant tumors such as advanced colorectal cancer and gastrointestinal stromal tumor (GIST). Its mechanism of action involves multiple pathways and molecules, thereby inhibiting tumor growth and spread.

The main mechanisms of action of regorafenib include inhibiting tumor angiogenesis, inhibiting tumor cell proliferation and promoting apoptosis (cell self-death), and inhibiting the metastasis and invasion capabilities of tumor cells. Through these effects, Regorafenib can interfere with the growth and spread of tumors, thereby extending patients' survival time and improving their quality of life.

The efficacy of regorafenib has been verified in clinical trials. For some patients with advanced tumors, especially those whose tumors have progressed despite other treatment options, regorafenib may be their first- or second-line treatment option. In clinical practice, Regorafenib is often used as a single drug or in combination with other drugs to achieve better therapeutic effects.

Compared with traditional chemotherapy drugs, Regorafenib is more specific and more targeted, so it usually brings fewer toxic side effects and better tolerance. However, like any drug, regorafenib may also cause some adverse reactions, including but not limited to fatigue, hypertension, hand-foot syndrome, etc. Therefore, when using regorafenib , doctors need to conduct a comprehensive evaluation based on the patient's specific situation to ensure safe and effective tumor treatment.

In general,regorafenib as a targeted drug, plays an important role in the treatment of advanced cancer. Its emergence provides new hope and opportunities for tumor patients who were once unable to be controlled through traditional treatments. However, specific treatment options and methods of use need to be fully discussed and considered by both patients and doctors to formulate the most appropriate treatment strategy.